Road to Alzheimer's Disease: The Pathomechanism Underlying

被引:13
|
作者
Anand, R. [1 ]
Kaushal, Alka [1 ]
Wani, Willayat Yousuf [1 ]
Gill, Kiran Dip [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India
关键词
Alzheimer's disease; Amyloid; Dementia; Neurofibrillary tangles; Oxidative stress; Senile plaques; Tau protein; AMYLOID-BETA-PEPTIDE; BLOOD-BRAIN-BARRIER; INDUCED NEURONAL APOPTOSIS; MILD COGNITIVE IMPAIRMENT; MESSENGER-RNA EXPRESSION; OXIDATIVE STRESS; PRECURSOR PROTEIN; APOLIPOPROTEIN-E; GENE-EXPRESSION; NEUROFIBRILLARY TANGLES;
D O I
10.1159/000332218
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD), the most common cause of dementia, results from the interplay of various deregulated mechanisms triggering a complex pathophysiology. The neurons suffer from and slowly succumb to multiple irreversible damages, resulting in cell death and thus memory deficits that characterize AD. In spite of our vast knowledge, it is still unclear as to when the disease process starts and how long the perturbations continue before the disease manifests. Recent studies provide sufficient evidence to prove amyloid beta (A beta) as the primary cause initiating secondary events, but A beta is also known to be produced under normal conditions and to possess physiological roles, hence, the questions that remain are: What are the factors that lead to abnormal A beta production? When does A beta turn into a pathological molecule? What is the chain of events that follows A beta? The answers are still under debate, and further insight may help us in creating better diagnostic and therapeutic options in AD. The present article attempts to review the current literature regarding AD pathophysiology and proposes a pathophysiologic cascade in AD. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:55 / 71
页数:17
相关论文
共 50 条
  • [1] Alzheimer's Disease: A General Introduction and Pathomechanism
    Finder, Verena H.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 : S5 - S19
  • [2] Role of RAGE in Alzheimer's Disease
    Cai, Zhiyou
    Liu, Nannuan
    Wang, Chuanling
    Qin, Biyong
    Zhou, Yingjun
    Xiao, Ming
    Chang, Liying
    Yan, Liang-Jun
    Zhao, Bin
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2016, 36 (04) : 483 - 495
  • [3] Pathological role of hypoxia in Alzheimer's disease
    Zhang, Xin
    Le, Weidong
    EXPERIMENTAL NEUROLOGY, 2010, 223 (02) : 299 - 303
  • [4] Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses
    Nasb, Mohammad
    Tao, Weichu
    Chen, Ning
    AGING AND DISEASE, 2024, 15 (01): : 43 - 73
  • [5] Melatonin in Alzheimer's Disease
    Lin, Li
    Huang, Qiong-Xia
    Yang, Shu-Sheng
    Chu, Jiang
    Wang, Jian-Zhi
    Tian, Qing
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (07): : 14575 - 14593
  • [6] APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis
    Uddin, Md. Sahab
    Kabir, Md. Tanvir
    Al Mamun, Abdullah
    Abdel-Daim, Mohamed M.
    Barreto, George E.
    Ashraf, Ghulam Md
    MOLECULAR NEUROBIOLOGY, 2019, 56 (04) : 2450 - 2465
  • [7] The preclinical phase of the pathological process underlying sporadic Alzheimer's disease
    Braak, Heiko
    Del Tredici, Kelly
    BRAIN, 2015, 138 : 2814 - 2833
  • [8] A Mitocentric View of Alzheimer's Disease Suggests Multi-Faceted Treatments
    Gibson, Gary E.
    Shi, Qingli
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S591 - S607
  • [9] The Case for Blood-Brain Barrier Dysfunction in the Pathogenesis of Alzheimer's Disease
    Jeynes, Brian
    Provias, John
    JOURNAL OF NEUROSCIENCE RESEARCH, 2011, 89 (01) : 22 - 28
  • [10] Advances in Alzheimer's disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches
    Atoki, Ayomide Victor
    Aja, Patrick Maduabuchi
    Ondari, Erick Nyakundi
    Shinkafi, Tijjani Salihu
    INTERNATIONAL JOURNAL OF FOOD PROPERTIES, 2023, 26 (01) : 2091 - 2127